Towards Understanding Microbial Drug Metabolism

Vayu Maini Rekdal, Graduate Student, Department of Molecular and Cellular Biology, Harvard University

Stories_insci Stories_insci on May 7, 2018

Vayu Maini Rekdal

Question
In less than 200 words, what main research questions are you working on? Please make sure to first include a brief context and background to your research, articulate your question(s) and conclude with why you think it’s important to study the them (i.e., the potential broader impacts).
Response
Gut microbes use diverse chemical reactions to metabolize many of the molecules we ingest, influencing their overall bioavailability and bioactivity. Our microbial co-inhabitants transform at least 50 different clinically used drugs including Levodopa (L-dopa), a dopamine precursor and the main treatment for Parkinson’s disease. Since the 1960s, it has been known that L-dopa is degraded by the gut microbiota. However, the specific microbe(s) and the enzyme(s) involved in L-dopa metabolism have remained elusive. Our goal is to identify and characterize the human-associated bacterial strains and enzymes degrading L-dopa. This work will provide molecular insight into a widespread gut microbial metabolic pathway while also uncovering disease-relevant enzymes from the human gut. More broadly, our work may enable strategies for predicting and manipulating microbial chemistry in the human body and beyond.